Iron status and the treatment of the anemia of prematurity

Pamela J. Kling; Joy J. Winzerling

doi:10.1016/S0095-5108(02)00002-7

Iron status and the treatment of the anemia of prematurity

Pamela J. Kling
, Joy J. Winzerling

Research output: Contribution to journal › Review article › peer-review

27 Scopus citations

Abstract

Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

Original language	English (US)
Pages (from-to)	283-294
Number of pages	12
Journal	Clinics in Perinatology
Volume	29
Issue number	2
DOIs	https://doi.org/10.1016/S0095-5108(02)00002-7
State	Published - 2002

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Obstetrics and Gynecology

Access to Document

10.1016/S0095-5108(02)00002-7

Cite this

@article{eb019a4cfe4f47b598b17135a57108f7,

title = "Iron status and the treatment of the anemia of prematurity",

abstract = "Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.",

author = "Kling, \{Pamela J.\} and Winzerling, \{Joy J.\}",

year = "2002",

doi = "10.1016/S0095-5108(02)00002-7",

language = "English (US)",

volume = "29",

pages = "283--294",

journal = "Clinics in Perinatology",

issn = "0095-5108",

publisher = "W.B. Saunders",

number = "2",

}

TY - JOUR

T1 - Iron status and the treatment of the anemia of prematurity

AU - Kling, Pamela J.

AU - Winzerling, Joy J.

PY - 2002

Y1 - 2002

N2 - Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

AB - Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

UR - https://www.scopus.com/pages/publications/0035990692

UR - https://www.scopus.com/pages/publications/0035990692#tab=citedBy

U2 - 10.1016/S0095-5108(02)00002-7

DO - 10.1016/S0095-5108(02)00002-7

M3 - Review article

C2 - 12168242

AN - SCOPUS:0035990692

SN - 0095-5108

VL - 29

SP - 283

EP - 294

JO - Clinics in Perinatology

JF - Clinics in Perinatology

IS - 2

ER -

Iron status and the treatment of the anemia of prematurity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this